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Visceral aortic patch aneurysm after
thoracoabdominal aortic repair: Conventional vs
hybrid treatment
Yamume Tshomba, MD, Luca Bertoglio, MD, Enrico M. Marone, MD, Germano Melissano, MD, and
Roberto Chiesa, MD, Milan, Italy
Objective: Visceral aortic patch (VAP) aneurysm repair following thoracoabdominal aortic aneurysm (TAAA) open
treatment carries high morbidity and mortality rates. The aim of this study is to compare the outcomes of our series of
patients who underwent redo VAP aneurysm open surgery (conventional group) with a selected group of high-risk
patients who underwent, in the same time period from 2001-2007, an alternative hybrid surgical and endovascular
approach (hybrid group).
Methods: Conventional group: Twelve patients (11 males, median age 71.5 years, range, 65 to 77 years) underwent VAP
aneurysm (median maximum diameter 62mm, range, 52 to 75mm) repair with re-inclusion technique via redo thoracophre-
nolaparotomy or bilateral subcostal laparotomy. Reimplantation of a single undersized VAP or separate revascularization of
one ormore visceral arteries was performed.Hybrid group: Seven patients (5males, median age 70 years, range, 63 to 78 years)
defined as at high risk for conventional surgery having American Society of Anesthesiology (ASA) class 3 or 4 associated with
a preoperative forced expiratory volume in 1 second (FEV1) <50% or an ejection fraction <40%, underwent VAP aneurysm
(median maximum diameter 73 mm, range, 62 to 84 mm) repair via median laparotomy, visceral arteries rerouting, and VAP
aneurysm exclusion using commercially available thoracic aortic endografts.
Results: Conventional group: Perioperative mortality was 16.7% andmajor morbidity 33.3%. One perioperative anuria was
successfully treated with bilateral renal artery stenting. No paraplegia or paraparesis were observed. At a median
follow-up of 2.3 years (range, 1.6-7 years), we observed one case of peri-graft fluid collection with sepsis at postoperative
day 46 requiring surgical drainage and prolonged antibiotic therapy and one case of renal failure at day 68 requiring
permanent hemodialysis. Hybrid group: perioperative mortality was 14.3% and major morbidity 28.6% with one case of
transient delayed paraplegia. At a median follow-up of 1.9 years (range, 0.3-6.8 years), we observed one case of late
pancreatitis (46 days postoperatively) resolved with pharmacologic treatment and one death due to an acute visceral grafts
thrombosis (78 days postoperatively). We did not observe other procedure-related deaths or complications, VAP
aneurysm growth, endoleak, and endograft migration.
Conclusion:Hybrid repair is clearly a feasible alternative to simple observation for patients unfit for redo VAP aneurysm
open surgery. However, despite our promising early results, new mid-term specific procedure-related complications have
been observed and a widespread use of this technique should be currently limited until longer-term follow-up is available.
(J Vasc Surg 2008;48:1083-91.)Thoracoabdominal aortic surgery has significantly
evolved over the last decades,1-4 but the surgical repair of
visceral aortic patch (VAP) aneurysms following thoraco-
abdominal aortic aneurysm (TAAA) with re-inclusion tech-
nique is, until now, related to high morbidity and mortality
rates (Table I).6-14
A hybrid approach consisting of visceral aortic de-
branching with rerouting of the visceral arteries and aneu-
rysm exclusion employing straight thoracic endografts has
been described in several reports for TAAA.15-19 An iso-
lated experience of VAP pseudoaneurysm repair with a
retrograde revascularization of the visceral vessels with sa-
phenous vein, VAP aneurysm coil embolization and en-
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doi:10.1016/j.jvs.2008.05.079dograft insertion into the previous aortic thoracoabdomi-
nal graft has been reported already in 2001 by Juvonen et
al,20 more recently, similar experiences for VAP aneurysms
have been reported (Table II).21,22 These isolated reports
earn citations having proposed an anecdotic alternative hybrid
approach that, compared to the conventional VAP re-grafting
and the pure endovascular repair, has several hypothetical
advantages in terms of invasiveness and feasibility.
This study prospectively analyzed and contrasted the
outcomes of our series of patients who underwent VAP
aneurysm repair with re-inclusion technique (conventional
group) with a selected group of high-risk patients who
underwent, in the same time period, an alternative ap-
proach consisting of visceral arteries rerouting and VAP
aneurysm endograft exclusion (hybrid group).
PATIENTS AND METHODS
Between 1988 and 2008, 344 patients (226 males,
median age 63 years, range, 34 to 83 years) underwent
treatment of TAAA (321 cases of conventional open repair
and 23 hybrid repairs) at our institution.
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median age 71.3 years, range, 63 to 78 years) who under-
went elective VAP aneurysm repair (median maximum
diameter 64 mm, range, 52 to 84 mm) between 2001 to
2007 (Table III). All these patients had prior TAAA repair
with the visceral vessels attached to the aortic graft as a VAP
(distal or proximal beveled anastomosis including visceral
vessels or patching of the aorta without tube graft were
excluded from this study). Eleven patients (58%) under-
went prior TAAA repair at our institution, 8 patients (42%)
underwent prior TAAA in a variety of other national cen-
ters. In 13 patients, the primary TAAA repair was for
atherosclerotic disease and in 6 patients for chronic dissec-
tion (2 cases - 10.5% - with a Marfan syndrome). The mean
time of detection of the VAP aneurysms was 5.8 2.3 years
after the original operation (we defined a VAP aneurysm as
having a diameter of 5 cm or more).
Twelve patients (11 males, median age 71.5 years,
range, 65 to 77 years) fit for thoracoabdominal aortic redo
procedure underwent conventional VAP aneurysm (me-
dian maximum diameter 62 mm, range, 52 to 75 mm)
open repair with re-inclusion technique (Table IV). Seven
high-risk patients (5 males, median age 70 years, range, 63
to 78 years) underwent VAP aneurysm (median maximum
diameter 73 mm, range, 62 to 84mm) hybrid repair (Table
V). The criteria we used from 2001 to define a patient with
VAP aneurysm as being at high-risk for conventional re-
inclusion technique and to select him for a hybrid treat-
ment, were, according to our anesthesiologists, the occur-
rence of a class 3 or 4 at the American Society of
Anesthesiologists (ASA) classification associated with a pre-
operative forced expiratory volume in 1 second (FEV1)
Table I. Literature review of the series of open repair of V
Authors Institution Year
Quinones-Baldrich et al2 California, USA 1997
Carrel et al3 Berne, Switzerland 1999
Gasparis et al4 New York, USA 2001
Dardik et al5 Baltimore, USA 2001
Clouse et al6 Boston, USA 2003
Dias et al7 Sao Paulo, Brazil 2003
Lombardi et al8 Philadelphia, USA 2003
Tshomba et al25 Milan, Italy 2004 
Suzuki et al9 Shizuoka, Japan 2005 
Le Maire et al10 Texas, USA 2006
Table II. Literature review of the series of endovascular a
Author Institution Yea
Hybrid treatment
Juvonen et al24 Oulu, Finland 200
Flye et al25 St Louis, USA 200
Bakken et al26 Rochester, USA 200
Pure endovascular treatment
Adam et al21 Birmingham, UK 20050% or an ejection fraction (EF) 40%.All the patients were operated under general and epi-
dural anesthesia. Cell salvage, rapid infusers, and transfu-
sion were used in all the patients. Preoperative cerebral
spinal fluid drainage (CSFD) was selectively used in 1
patient who underwent open repair in which the arteries
participating to collateral network providing spinal cord
blood flow were preoperatively reduced and in 1 patient
who underwent hybrid repair in which patent re-implanted
intercostal arteries were planned to be sacrificed (Table IV
and V).
Conventional group. The re-inclusion technique was
performed in all the cases, via a redo thoracophrenolapa-
rotomy in 10 cases, and a bilateral subcostal laparotomy in
2 cases. All the visceral arteries and all the renal arteries were
preoperatively patent and were always revascularized dur-
ing the re-inclusion technique. The re-implantation of a
single undersized 4-vessel VAP was performed in 2 cases, in
which the first VAP had been created with a large amount
of aortic tissue externally to the renal arteries and above the
celiac trunk, the visceral arteries were not largely displaced
and the intraoperative hemodynamic instability and diffuse
bleeding induced us to perform the fastest possible proce-
dure. In the other 10 cases, a separate revascularization of
one or more visceral arteries was performed. Specifically a
3-vessel VAP (with strictly close celiac trunk, superior mes-
enteric artery, and one renal artery) with selective revascu-
larization of the other renal artery was performed in 3
cases, and a 2-vessel VAP with selective revascularization
of both the renal arteries was performed in 2 cases. Revas-
cularization of all the visceral vessels was performed in 5
cases, in the first case, 4 single separated bypasses were used
and in the other 4 cases, a commercially available thoracoab-
neurysms with re-inclusion technique
Cases Mortality Spinal cord Renal failure
1 0 1 0
1 0 0 0
1 0 0 0
5 25% 0% 0%
2 0 0% 50%
1 0 0 0
3 33% 0% 0
5 20% 0% 40%
1 0 0 0
1 0 0 0
brid repair of VAP aneurysms
Cases Mortality Spinal cord Renal failure
1 0 0 0
1 0 0 0
1 0 0 0
1 0 0 0AP and hy
r
1
4
7dominal 4-branched graft specific for inline replacement of
mL/m
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 5 Tshomba et al 1085the visceral aorta (Coselli Thoracoabdominal Graft
Gelweave, Vascutek LTD, Renfrewshire, UK) was used
for re-grafting (Fig 1). No extracorporeal circulation was
used. Before and during supraceliac aortic cross-clamp-
ing, diuresis was forced by systemic infusion of furo-
semide and mannitol (0.5 g/kg). An intraoperative hy-
Table III. Patients risk factors grading system for cardiov
Society for Vascular surgery/North American Chapter of t
(SVS/ISCVS) and according to the Goldman revised card
Risks factors
Male
Age (years)
ASA score
1
2
3
4
5
Cardiac risk index*
I
II
III
IV
Hypertension
0 (diastolic  90 mm Hg)
1 (easily controlled, single drugs)
2 (requires 2 drugs)
3 (2 drugs or uncontrolled)
Diabetes
0 (none)
1 (adult onset, diet controlled)
2 (adult onset, oral medication-controlled)
3 (adult onset, insulin controlled)
4 (juvenile onset)
Smoking
0 (none; abstinence  10 yrs)
1 (none; abstinence 1-10 yrs)
2 ( 1 pack/day or abstinence 1 yrs)
3 (current 1  pack/day)
Hyperlipemia
0 (within normal limits for age)
1 (mild elevation, diet controlled)
2 (types II, III, or IV, strict diet control)
3 (requires drug control)
Pulmonary status**
0
1
2
3
Renal status***
0
1
2
3
ASA, American Society of Anesthesiology.
*Perioperative cardiac risk, according to the Goldman revised cardiac risk in
**Pulmonary status: 0 asymptomatic, normal chest X-ray, pulmonary func
mild X-ray parenchymal changes, PFT 65 to 80% of predicted; 2  betwee
maximal voluntary ventilation less than 28 l/min or less than 50% of predicte
hypertension.
***Renal status: 0  no known renal disease, serum creatinine 1.5 mg/d
clearance 30-50 mL/min; 2  creatinine 3.0-6.0 mg/dL, clearance 15-30
with transplant.pothermic perfusion through 9F Pruitt-Inhara occlusionperfusion balloon catheters (LeMaitre-Vascular, Inc,
Burlington, Mass) of the celiac and superior mesenteric
arteries with cold crystalloid (lactate ringer at 4°C) and
of the renal arteries with cold crystalloid (lactate ringer at
4°C) supplemented with mannitol 18% 70 mL and 6-32
methylprednisolone 500 mg was routinely used main-
ar risk factors and co-morbidity tabulated according to
ternational Society for Cardiovascular Surgery
sk index43
pen repair (n  12) Hybrid repair (n  7)
11 5
1.5 yrs (r. 65-77) 70 yrs (r. 63-78)
0 0
5 (41.7%) 0
4 (33.3%) 4 (57.1%)
3 (25%) 3 (42.9%)
0 0
6 (50%) 1 (14.3%)
4 (33.3%) 4 (57.1%)
2 (16.7%) 2 (28.6%)
0 0
1 (8.3%) 1 (14.3%)
7 (58.3%) 6 (85.7%)
3 (25%) 0
1 (8.3%) 0
11 (91.7%) 6 (85.7%)
0 0
0 1 (14.3%)
1 (8.3%) 0
0 0
3 (25%) 1 (14.3%)
3 (25%) 2 (28.6%)
5 (41.7%) 3 (42.9%)
1 (8.3%) 1 (14.3%)
2 (16.7%) 1 (14.3%)
4 (33.3%) 2 (28.6%)
1 (8.3%) 0
5 (41.7%) 4 (57.1%)
1 (8.3%) 0
4 (33.3%) 0
5 (41.6%) 4 (57.1%)
2 (16.7%) 3 (42.9%)
9 (75%) 6 (85.7%)
3 (25%) 1 (14.3%)
0 0
0 0
3
st (PFT) 20% of predicted; 1 asymptomatic or mild dyspnoea on exertion,
d 3; 3  vital capacity less than 1.85 L, FEV1 less than 35% of predicted,
greater than 45mmHg, supplemental oxygen use necessary or pulmonary
atinine clearance greater than 50 mL/min; 1  creatinine 1.5-3.0 mg/dL,
in; 3  creatinine 6.0 mg/dL, clearance 15 mL/min or on dialysis orascul
he In
iac ri
O
7
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risk of coagulopathy.
Hybrid group. All patients evaluated for a hybrid
repair of the VAP aneurysm received a multislice computed
tomography (CT) scan with 1 mm intervals and multipla-
nar reconstructions (Aquilion 16 and 64; Toshiba Medical
Systems, Tokyo, Japan) for planning and sizing. In partic-
ular, the intercostal arteries patency was studied, and, when
the Adamkiewicz artery was detected, the intercostal artery
feeding was planned to be spared. In all the cases, the
diameter of previously inserted thoracoabdominal graft
measured at preoperative CT scan allowed us to plan an
oversizing of at least 10-15%.
All the patients underwent one-stage VAP aneurysm
hybrid repair with thoracoabdominal aortic debranching,
visceral arteries rerouting with retrograde bypass grafts, and
TAAA exclusion using commercially available thoracic en-
dografts as summarized in Table V. All the procedures were
performed in the operating room.
The abdominal aorta, common iliac arteries, and the
first 2 cm from the origin of the common hepatic artery,
Table IV. San Raffaele Scientific Institute, Università “Vi
aneurysm repair developed after a primary thoracoabdomin
inclusion technique. The results are reported in accordance
repair prepared and revised by the Ad Hoc Committee for
(SVS/AAVS)23
N°
Age
(yrs) Sex
VAP Ø
(mm) Previous type TAAA Revised
#1 71 M 64 III CT, SMA, R
#2 77 M 58 II SMA, CT, R
(LRA sele
revascula
#3 72 M 52 III (Chronic
dissection, Marfan)
CT, SMA, L
(RRA sel
revascula
#4 67 F 68 III CT, SMA, (
RRA sele
revascula
#5 68 M 56 IV Selective by
#6 74 M 54 III CT, SMA, R
#7 71 M 63 II CT, SMA, R
(LRA sele
revascula
#8 69 M 74 III (Chronic
dissection)
CT, SMA, (
RRA sele
revascula
#9 74 M 61 II (Chronic
dissection)
4 branched
#10 73 M 68 II 4 branched
#11 65 M 75 III 4 branched
#12 77 M 58 II (Chronic
dissection)
4 branched
VAP Ø, Diameter of visceral aortic patch; TAAA, thoracoabdominal aortic
mesenteric artery; RRA, right renal artery; LRA, left renal artery; MI, myosuperior mesenteric artery, and renal arteries were exposedthrough a transperitoneal mid-line approach with the pa-
tient in a supine position.
We used as donor vessel for the retrograde grafts the
infrarenal native or the previously grafted (Fig 2, B) aorta or
the right common iliac artery when of good quality. Over-
all, 25 retrograde visceral bypasses were performed (6 to
the celiac trunk, 7 to the superior mesenteric artery, and 12
to renal arteries). We aborted the revascularization of one
renal artery for technical concerns (Fig 2) and intentionally
planned the covering without revascularization of one renal
artery and of one celiac trunk. Synthetic grafts (Dacron
graft - 6 and 8 mm diameter) were used in all the cases. We
used separate bypass for each recipient vessel, customized
“Y” grafts, customized trifurcated grafts, or single bypass
with sequential graft technique (Fig 2) related to the spe-
cific anatomy of every case. For celiac trunk revasculariza-
tion, the graft was routed in front of the renal vein behind
the pancreas, an arteriotomy was made in the common
hepatic artery and an end-to-side anastomosis was made.
An end-to-end anastomosis was usually preferred for the
superior mesenteric artery, and this type of anastomosis was
alute” experience: patients underwent operation for VAP
rtic aneurysm (TAAA) repair with conventional re-
h the current reporting standards for endovascular aortic
dardized Reporting Practices in Vascular Surgery
h CSFD Mortality Morbidity
Midterm
results
LRA No No Bleeding (G3)23 OK
n)
No No Renal
Insufficiency
(G2)23
Death: MI
n)
No Yes (MOF) Coagulopathy
(G3)23
—
and
n)
No No Cardiac (G2)23 Death: Stroke
s No No No OK
LRA No No No OK
n)
No No Renal
Insufficiency
(G2)23
Perigraft
Collection
Pulmonary
(G3)23
and
n)
No No Pulmunary
(G3)23
OK
No No Bleeding (G3)23 OK
Preop Yes (MOF) No —
No No No Renal
Insufficiency
(G3) 23
No No Bleeding (G3)23 OK
rysm; CSFD, cerebrospinal fluid drainage, CT, celiac trunk, SMA, superior
infarction; MOF, multiple organ failure.ta – S
al ao
wit
Stan
patc
RA,
RA,
ctive
rizatio
RA,
ective
rizatio
LRA
ctive
rizatio
passe
RA,
RA,
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rizatio
LRA
ctive
rizatio
graft
graft
graft
graftalways used for the renal arteries. Before and during renal
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 5 Tshomba et al 1087artery cross-clamping, diuresis was forced by systemic infu-
sions of furosemide and mannitol (0.5 g/kg). When the
time of renal ischemia was longer than 10 minutes for
technical issues, such as in case of renal artery endarterec-
tomy or difficult anastomosis, during the renal artery cross-
clamping a bolus of 300 mL of cold crystalloid (lactate
ringer at 4°C) supplemented withmannitol 18% 70mL and
6-methylprednisolone 500mg was perfused into the orifice
of the renal artery with an occlusion perfusion balloon
catheter (Pruitt- Inhara 9 Fr) maintaining the nasopharyn-
geal temperature always above the 35°C using fluid warmer
systems. Then a continuous perfusion of approximately 500
mL was administered. In all reconstructions, the grafted ves-
sels were ligated proximally to prevent retrograde perfusion of
the sac after endovascular exclusion of the aneurysm.
The access vessel for endograft insertion in all the cases
was the common femoral artery (exposed through an in-
guinal incision) being of appropriate diameter and of good
quality without excessive tortuosity of iliac axis in all the 7
patients selected for hybrid repair. We preferred this access
site compared to iliac approach that does not require groin
incision, because it allowed a shallower angle of entry of the
endograft introducer into the artery and satisfactory hemo-
stasis during the procedure (allowing the arteriotomy to
collapse with the introducer in site) without the use of a
conduit. A radio-opaque marker was placed at the origin of
the more proximal visceral graft when originating from
native or grafted abdominal aorta. Three commercially
available stent-grafts (Zenith Cook TX2 stent-graft – Cook
Inc, Bloomington, Ind; the Valiant thoracic stent-graft –
Medtronic, Minneapolis, Minn; Bolton Relay – Bolton
Medical, Sunrise, Fla) were used and 1 or 2 stent-grafts
were deployed in each patient (Table V). A completion
aortography was carried out after deployment of the en-
dografts. Stent-graft ballooning was performed selectively.
The access sites were repaired by direct suture.
Postoperative follow-up. All the patients in both
groups were evaluated with postprocedure contrast CT
scans with scheduled follow-up imaging at 3 and 6 months
and yearly thereafter. Clinical follow-up was also done at
regular intervals of 6 months.
Based to a prospectively compiled database, we ana-
lyzed and compared the outcomes of the two groups. We
analyzed the outcomes in our patients, reporting the results
of hybrid repair in accordance with the current reporting
standards for endovascular aortic repair prepared and re-
vised by the Ad Hoc Committee for Standardized Report-
ing Practices in Vascular Surgery (SVS/AAVS).23
RESULTS
Preoperative comorbidities and risk factors were higher
in the hybrid group (Table III) but a statistical analysis
comparison was not feasible with such small subsets of
patients. Aetiology and extent of prior TAAA repair were
not notably different between the two groups (Table IV
and V). No patients were lost at follow-up.
Conventional group (12 cases) (Tables IV and VI).
No intraoperative deaths occurred. The median proceduretime was 210 minutes (range, 165 to 301 minutes). A
median of 8.7 units of packed red blood cells were trans-
fused for a median blood loss of 1350 mL (range, 850 to
6500 mL). All patients were admitted to the intensive care
unit where they stayed for a median of 2 days (range, 1 to
23 days).
There were two deaths on postoperative day 3 and 5
due tomulti-organ failure for a total perioperativemortality
of 16.7% (compared to 8.4% in our overall series of 321
patients who underwent TAAA open repair).
Postoperative major morbidity included two cases of
acute renal failure reversed with temporary postoperative
dialysis in 2 patients (16.7%). One patient, in which an
undersized VAP was recreated, developed intraoperative
bilateral renal artery dissection leading to perioperative
anuria and was treated with immediate bilateral renal artery
stenting without permanent renal impairment. Respiratory
failure requiring intubation for more than 48 hours was
observed in 2 patients (16.7%). No case of spinal cord
ischemia was observed. The mean length of hospital stay
was 9 days (range, 6 to 61 days). The perioperative major
morbidity in the group of patients who underwent VAP
aneurysm open repair was thus 33.3%, with a combined rate
of perioperative renal complications, respiratory failure, and
paraplegia of 41.5%, compared to 27.9% in our overall
series of 321 patients undergoing TAAA open repair.
At a median follow-up of 4.3 years (range, 1.6-7.9
years) no significant aortic repair-related complications had
been reported. We observed one case of peri-graft fluid
collection with sepsis on postoperative day 46 requiring
surgical drainage and prolonged antibiotic therapy and one
case of renal failure on postoperative day 68 requiring
permanent hemodialysis. In the 2 patients who underwent
undersized 4-vessel VAP recreation, at the last CT follow-up
available we observed a slight VAP dilatation compared to
the diameter measured at the postprocedure contrast CT
scans (respectively of 4 mm at 4 years for an overall VAP
diameter of 37 mm in the first patient, and 3 mm at 2 years
for an overall VAP diameter of 32 mm in the second
patient). No other VAP or branch vessel-related complica-
tions were seen. We recorded two unrelated deaths (acute
myocardial infarction and stroke, respectively).
Hybrid group (7 cases) (Tables V and VI). Hybrid
repair of VAP aneurysm was technically successful in all the
patients. The median procedure time was 241 minutes
(range, 187 to 465 minutes). A median of 4.7 units of
packed red blood cells were transfused for a median blood
loss of 480 mL (range, 380 to 2900 mL). All patients were
admitted to the intensive care unit where they stayed for a
median of 3 days (range, 1 to 27 days). No endograft
access-site adjunctive maneuvers or additional intraopera-
tive cuff placement was required.
There were no intraoperative deaths. One perioperative
death (14.3%) was recorded due to coagulopathy. Postop-
erative major morbidity was of 28.6% with one case of
transient delayed paraplegia (2 days postoperatively), which
completely resolved with institution of spinal cord fluid
drainage and one case of transient doubling of the serum
aneur
ltiple
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(range, 13 to 26 days). At a median follow-up of 1.9 years
(range, 0-2.2 years) we observed one case of late pancreati-
tis (46 days postoperatively) which resolved with medical
care and one death due to acute visceral grafts thrombosis
78 days postoperatively during a severe episode of heart
failure. We did not observe any other related complications
or death, VAP aneurysm growth, endoleak, and endograft
migration. One patient died 38 months after VAP hybrid
repair during an aortic arch ruptured aneurysm emergency
open repair.
DISCUSSION
The natural history, growth rate, and risk of rupture of
Fig 1. A, Preoperative angioCT of a patient with previ
repair with a 62 mm VAP aneurysm. B, Intraoperativ
revascularization of the four visceral vessels with Coselli
shire, UK). C, Six month postoperative angioCT scan de
visceral vessels.
Table V. San Raffaele Scientific Institute, Università “Vita
aneurysm repair developed after a primary thoracoabdomin
results are reported in accordance with the current reportin
revised by the Ad Hoc Committee for Standardized Repor
N° Age (yrs) Sex VAP Ø (mm) Prev
#1 70 F 64 II
#2 68 M 79 III
#3 77 M 84 II
#4 63 F 62 III
#5 67 M 73 II (Chroni
#6 74 M 69 III
#7 78 M 75 II (Chroni
VAP Ø, diameter of visceral aortic patch; TAAA, thoracoabdominal aortic
mesenteric artery; RRA, right renal artery; LRA, left renal artery; MOF, muVAP aneurysms have never been completely clarified but itmay be hypothesized that VAP aneurysms behave as saccu-
lar aneurysms which are at high risk of rupture.5,24 They are
usually considered a rare late complication following TAAA
open repair, mainly limited to patients with Marfan syn-
drome or other connective tissue disorders, but their real
incidence is likely underestimated. VAP dilatations and
aneurysms are not uncommon after atherosclerotic and
dissecting TAAA repair, especially when large tube grafts
(diameter greater than 28 mm) with a single large VAP also
including the left renal artery.25 Furthermore, since Craw-
ford et al5 proposed his ‘inclusion technique’ in 1978,
survival of patients has considerably improved, especially in
“high-volume” centers operating on relatively young pa-
tients with the current multimodality approaches of organ
pe II thoracoabdominal aortic aneurysm (TAAA) open
w of open repair of the VAP aneurysm with separate
coabdominal graft (Gelweave, Vascutek LTD, Renfrew-
trates VAP aneurysm resolution and patency of the four
lute” experience: patients underwent operation for VAP
rtic aneurysm (TAAA) repair with hybrid technique. The
ndards for endovascular aortic repair prepared and
Practices in Vascular Surgery (SVS/AAVS)23
ype TAAA Outflow arteries In-flow artery
CT, SMA, RRA Aorta
CT, SMA, RRA Right iliac a.
SMA, RRA, LRA Right iliac a.
CT, SMA, RRA, LRA Right iliac a.
ection, Marfan) CT, SMA, RRA, LRA Aortic graft
CT, SMA, RRA, LRA Right iliac a.
ection) CT, SMA, RRA, LRA Aortic graft
ysm; CSFD, cerebrospinal fluid drainage; CT, celiac trunk; SMA, superior
organ failure.ous ty
e vie
thora
mons– Sa
al ao
g sta
ting
ious t
c diss
c dissprotection.26-29 So long-term complications such as the
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be a common concern.30,31
The visceral aortic re-grafting for VAP aneurysm with
the re-inclusion technique is a demanding procedure. The
redo left-sided thoracotomy is well known to be associated
with postoperative respiratory failure especially in case of
“frozen chest” in which the risk of severe iatrogenic pul-
monary injuries and even aborting the procedure is high.32
During TAAA repair, a redo thoracotomy has been shown
to be associated with major bleeding, an increased rate of
organ failure, longer total aortic clamping time, longer
operation time, and reduced long-term survival.33-36 Fur-
thermore, if extracorporeal circulation is required, pericar-
dial or proximal aortic adhesions may also increase the
technical challenges and risk of major bleeding at the site of
outflow cannulation, especially if a left atrium, pulmonary
Fig 2. A, Preoperative angioCT scan of a patient w
(TAAA) open repair with a 79 mm VAP aneurysm. Plea
with a stenosis at the origin of the celiac trunk (CT) an
view of the retrograde revascularization from the right
superior mesenteric artery (SMA), and of the celiac tru
free from retroperitoneal adhesions after Kocker ma
performed because it could not be dissected safely du
adhesions of retroperitoneal tissue. C, Postoperative
stent-graft (blue) of the VAP aneurysm without end
visceral arteries (red).
Table V. Continued
CSFD Endograft Mortality
Postop Valiant No Spinal Cord Is
No Valiant No Bleeding (G3)
No Zenith TX2 No No
No Zenith TX2 No Bleeding (G3)
Preop Bolton Relay No No
No Valiant Yes (MOF) Coagulopathy
No Zenith TX2 No Renal Insufficvein, or distal aortic arch re-cannulation is required.34 Also,the retroperitoneal re-dissection is often challenging due to
the common local severe inflammation making the VAP
difficult to re-dissect and increasing the risk of major bleed-
ing.17
Another main challenge in VAP aneurysm re-grafting is
related to the poor quality of the VAP wall. We experienced
that when a new undersized VAP is recreated after failed
VAP, the risk of major bleeding from the anastomosis after
aortic declamping is increased, and we believe also the risk
of late recurrent VAP aneurysm to be increased so that this
practice should be limited to very particular cases. Also, the
ostia of the visceral arteries are commonly severely diseased
and the common strategy to reduce the size of revised VAP
by stitches into the visceral ostia increases the risk of visceral
artery dissection. Our case of postoperative anuria that
resolved with immediate bilateral renal arteries stenting was
revious type III thoracoabdominal aortic aneurysm
te the complete displacement of visceral arteries origin
e superior mesenteric artery (SMA). B, Intraoperative
mon iliac artery of the right renal artery (RRA), of the
T). The right renal artery was dissected and prepared
r. Revascularization of the left renal artery was not
its displacement by the VAP aneurysm and the tight
can demonstrates complete exclusion with a Valiant
and patency of the retrograde revascularization of
orbidity Midterm results
ia (G1)23 Death: Aortic Arch Rupture
nal Insufficiency (G1)23 Death: Visceral Graft Thrombosis
OK
Pancreatitis
OK
23 —
(G2)23 OKith p
se no
d th
com
nk (C
neuve
e to
CT s
oleakM
chem
23 Re
23
(G3)
iencylikely related to this mechanism which led to renal artery
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branched grafts reduce the aortic tissue used for re-grafting
by allowing circumferential selective anastomosis to each
visceral vessel with smaller stitches. This surgical option
may represent an interesting solution to resolve the prob-
lem of VAP perioperative bleeding, artery dissection, and of
the recurrent revised VAP dilatation.
Although endovascular branch vessel technology
makes pure endovascular TAAA repair technically feasible
by preserving visceral end organ perfusion, the use of
fenestrated and branched endografts is a complex and time
consuming procedure with limited long-term follow-up
intervention, currently limited to few institutions.37-39
Pure endovascular VAP aneurysm repair has been occasion-
ally reported (Table II), but refinement of device design
and delivery technique facilitating guide wires engage-
ment and endografting within largely displaced visceral
arteries are likely required to make this technology widely
available for these kind of lesions.40
Hybrid VAP repair is a more feasible alternative
approach and compared to the conventional VAP re-
grafting, has several hypothetical advantages. First of all,
re-thoracotomy and extensive retroperitoneal redissection
to control the previously inserted aortic graft are avoided.
Second, the problem of the poor quality of the tissue of the
VAP is virtually eliminated because the anastomoses are
performed with the visceral arteries 1-3 cm far from the
VAP.Moreover, the VAP aneurysms have ideal straight and
long “in-graft” proximal and distal necks and in the cases of
endografts landed in pre-existing or new aortic tube grafts,
endoleak and migration have never been reported.17 How-
ever, a significant concern of hybrid approach to VAP
aneurysms is renal artery revascularization. The presence of
tight adhesion due to the previous aortic surgery and the
displacement of visceral arteries due to VAP morphology
makes dissection of renal arteries challenging and, in our
series, we decided to abort revascularization of one renal
artery for this issue.
The avoidance of supraceliac clamping during the hy-
brid repair and the shortened duration of visceral ischemia
compared to the VAP aneurysm regrafting will also poten-
tially improve perioperative hemodynamic stability and re-
duce hypotension that has recently emerged as an indepen-
dent risk factor of paraplegia during both endovascular and
Table VI. Thirty-day outcomes in open and hybrid repair
30-day outcome Open repai
Technical success 12 (1
Intraoperative death 0%
Median procedure time 210 min (range
Median blood loss 1350 mL (range
Intensive care unit stay 2 days (1-23 d
30-day deaths 2 (16
30-day major morbidity 4 (33
Mean length of hospital stay 9 days (rangeopen thoracic aortic repair.41-43 The only case of spinalcord ischemia we reported in our series was a delayed
transient paraplegia that occurred in 1 patient in the hybrid
group in which an intercostal artery patch with a patent
intercostal artery was unintentionally partially covered. The
delayed symptoms completely resolved with emergent spi-
nal fluid drainage.
CONCLUSION
In our preliminary series of VAP aneurysm hybrid
repair, despite the particularly poor condition of the pa-
tients we selected, we found encouraging early results with
mortality and morbidity rates similar to the conventionally
treated patients. However, at mid-term follow-up, new
procedure-related complications such as pancreatitis and
visceral graft thrombosis were observed. Larger series and
longer follow-ups are required in order to establish if
ongoing improvements in endovascular techniques and
rapidly accumulating experience with hybrid procedures
will change our approach to VAP aneurysm repair.
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